n(g),n(g')-dimethyl-l-arginine has been researched along with Recrudescence in 8 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the prognostic value of serum levels of asymmetric dimethylarginine (ADMA) in patients with stable coronary heart disease (CHD) thus explore a potential biomarker of "toxin syndrome" in CHD." | 7.91 | Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease. ( Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA, 2019) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 7.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 7.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| "Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor, which has been associated with total and cardiovascular mortality in various clinical settings." | 5.39 | Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. ( Böger, R; Breitling, LP; Brenner, H; Koenig, W; Maas, R; Rothenbacher, D; Schwedhelm, E; Siegerink, B; Vossen, CY, 2013) |
| "Guanidino compounds, including l-homoarginine (l-hArg), symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA) and l-arginine (l-Arg) are associated with mortality, fatal strokes, stroke incidence, and atherosclerosis." | 3.91 | Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA ( Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G, 2019) |
| "To examine the prognostic value of serum levels of asymmetric dimethylarginine (ADMA) in patients with stable coronary heart disease (CHD) thus explore a potential biomarker of "toxin syndrome" in CHD." | 3.91 | Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease. ( Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA, 2019) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 3.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 3.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| "Patients with AF-recurrence were older, had a higher proportion of hypertension and long-standing persistent AF." | 1.40 | Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation. ( Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD, 2014) |
| "Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor, which has been associated with total and cardiovascular mortality in various clinical settings." | 1.39 | Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. ( Böger, R; Breitling, LP; Brenner, H; Koenig, W; Maas, R; Rothenbacher, D; Schwedhelm, E; Siegerink, B; Vossen, CY, 2013) |
| "Eleven patients with thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) were investigated with respect to plasma concentrations of L-arginine, a substrate for nitric oxide (NO) and asymmetrical dimethyl arginine (ADMA), during active disease and after recovery." | 1.30 | The arginine-nitric oxide pathway in thrombotic microangiopathy. ( Herlitz, H; Petersson, A; Sigström, L; Wennmalm, A; Westberg, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordts, K | 1 |
| Grzybowski, R | 1 |
| Lezius, S | 1 |
| Lüneburg, N | 1 |
| Atzler, D | 1 |
| Neu, A | 1 |
| Hornig, S | 1 |
| Böger, RH | 1 |
| Gerloff, C | 1 |
| Magnus, T | 1 |
| Thomalla, G | 1 |
| Schwedhelm, E | 2 |
| Grant, PJ | 1 |
| Choe, CU | 1 |
| Xu, H | 1 |
| Chen, Z | 1 |
| Shang, QH | 1 |
| Gao, ZY | 1 |
| Yu, CA | 1 |
| Shi, DZ | 1 |
| Chen, KJ | 1 |
| Lim, HS | 1 |
| Willoughby, SR | 1 |
| Schultz, C | 1 |
| Chakrabarty, A | 1 |
| Alasady, M | 1 |
| Lau, DH | 1 |
| Roberts-Thomson, KC | 1 |
| Worthley, MI | 1 |
| Young, GD | 1 |
| Sanders, P | 1 |
| Yang, L | 1 |
| Xiufen, Q | 1 |
| Shuqin, S | 1 |
| Yang, Y | 1 |
| Ying, S | 1 |
| Yanwei, Y | 1 |
| Wei, F | 1 |
| Dechun, Y | 1 |
| Kleinedler, JJ | 1 |
| Orchard, EA | 1 |
| Foley, JD | 1 |
| Rogers, LK | 1 |
| Hebert, VY | 1 |
| Dugas, TR | 1 |
| Siegerink, B | 1 |
| Maas, R | 1 |
| Vossen, CY | 1 |
| Koenig, W | 1 |
| Böger, R | 1 |
| Rothenbacher, D | 1 |
| Brenner, H | 1 |
| Breitling, LP | 1 |
| Herlitz, H | 1 |
| Petersson, A | 1 |
| Sigström, L | 1 |
| Wennmalm, A | 1 |
| Westberg, G | 1 |
| Yoo, JH | 1 |
| Lee, SC | 1 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Recrudescence
| Article | Year |
|---|---|
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Stud | 2019 |
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease.
Topics: Arginine; Biomarkers; Coronary Disease; Humans; Odds Ratio; Recurrence; Risk Factors; ROC Curve; Syn | 2019 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium | 2014 |
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Body Surface Potential Mapping; Catheter Ablation; Cohort | 2011 |
A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting.
Topics: Angioplasty, Balloon; Animals; Arginine; Biomarkers; Carotid Arteries; Carotid Artery Injuries; Caro | 2011 |
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Topics: Aged; Arginine; Biomarkers; Cause of Death; Chromatography, Liquid; Coronary Disease; Female; Follow | 2013 |
The arginine-nitric oxide pathway in thrombotic microangiopathy.
Topics: Adult; Aged; Arginine; Child, Preschool; Enzyme Inhibitors; Hemolytic-Uremic Syndrome; Humans; Middl | 1997 |
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme | 2001 |